CIRB Studies

Below is the current list of studies covered by the CIRB. It includes both Available to Open and Completed studies. Study documents approved after July 1, 2013 for all covered studies are available on the CTSU website.

To request documents approved before July 1, 2013, please contact the CIRB Helpdesk.

Displaying 11 - 20 of 1130
Study Number Lead Group Study Title CIRB Study Status
WF-1804CD NCORP-Wake Forest University Assessing effectiveness and implementation of an EHR tool to assess heart health among survivors (AH-HA) Cancer Prevention and Control CIRB Available to Open
WF-1803CD NCORP-Wake Forest University Supportive Care Service Availability for Cancer Caregivers in Community Oncology Practices Cancer Prevention and Control CIRB Completed
WF-1802 NCORP-Wake Forest University Influence of Primary Treatment for Prostate Cancer on Work Experience (PCW) Cancer Prevention and Control CIRB Available to Open
WF-1801 NCORP-Wake Forest University A Single Arm, Pilot Study of Ramipril for Preventing Radiation-Induced Cognitive Decline in Glioblastoma (GBM) Patients Receiving Brain Radiotherapy Cancer Prevention and Control CIRB Available to Open
WF-10217 NCORP-Wake Forest University Work Ability in Young Adult Survivors (WAYS) Cancer Prevention and Control CIRB Available to Open
UWI21-06-01 CP-CTNet_CLO-University of Wisconsin Pilot study of GCC agonists to identify a cyclic-GMP signal in duodenal tissue of volunteers Cancer Prevention and Control CIRB Available to Open
UWI2016-08-01 CP-CTNet_CLO-University of Wisconsin Pilot Study of Daily Exemestane in Women with Complex Atypical Hyperplasia of the Endometrium / Endometrial Intraepithelial Neoplasia or Grade 1 Endometrial Cancer Cancer Prevention and Control CIRB Available to Open
UWI2016-07-01 CP-CTNet_CLO-University of Wisconsin Phase IIB Randomized, Placebo-Controlled Trial of ACTOplus met® XR in Subjects with Stage I-IV Squamous Cell Carcinoma of the Oral Cavity or Oropharynx Prior to Definitive Treatment Cancer Prevention and Control CIRB Completed
UWI2015-05-01 CP-CTNet_CLO-University of Wisconsin Phase Ib 9cUAB30 in Early Stage Breast Cancer to Evaluate Biologic Effect Cancer Prevention and Control CIRB Available to Open
UWI2014-03-01 CP-CTNet_CLO-University of Wisconsin A Phase I Trial of the Safety and Immunogenicity of a DNA Plasmid Based Vaccine (WOKVAC) Encoding Epitopes Derived from Three Breast Cancer Antigens (IGFBP-2, HER2, AND IGF-1R) in Patients with Breast Cancer Cancer Prevention and Control CIRB Available to Open
Displaying 11 - 20 of 1130